Glassman Wealth Services’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,310
| Closed | -$18.2K | – | 1443 |
|
|
2023
Q4 | $18.2K | Buy |
1,310
+10
| +0.8% | +$139 | ﹤0.01% | 710 |
|
|
2023
Q3 | $17.4K | Sell |
1,300
-170
| -12% | -$2.27K | ﹤0.01% | 689 |
|
|
2023
Q2 | $18.6K | Buy |
1,470
+40
| +3% | +$505 | ﹤0.01% | 637 |
|
|
2023
Q1 | $16.3K | Buy |
1,430
+25
| +2% | +$285 | ﹤0.01% | 686 |
|
|
2022
Q4 | $14.5K | Buy |
1,405
+495
| +54% | +$5.12K | ﹤0.01% | 738 |
|
|
2022
Q3 | $10K | Buy |
910
+315
| +53% | +$3.46K | ﹤0.01% | 799 |
|
|
2022
Q2 | $7K | Buy |
595
+140
| +31% | +$1.65K | ﹤0.01% | 922 |
|
|
2022
Q1 | $5K | Buy |
455
+15
| +3% | +$165 | ﹤0.01% | 1009 |
|
|
2021
Q4 | $6K | Buy |
440
+370
| +529% | +$5.05K | ﹤0.01% | 942 |
|
|
2021
Q3 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 1440 |
|